Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$8.79 - $11.51 $8.61 Million - $11.3 Million
979,896 Added 79.17%
2,217,669 $25.4 Million
Q3 2023

Nov 14, 2023

BUY
$8.25 - $11.35 $873,625 - $1.2 Million
105,894 Added 9.36%
1,237,773 $11.9 Million
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $11.3 Million - $13 Million
1,121,686 Added 11004.47%
1,131,879 $12 Million
Q1 2023

May 15, 2023

BUY
$10.37 - $12.56 $105,701 - $128,024
10,193 New
10,193 $107,000
Q1 2021

May 17, 2021

SELL
$9.04 - $11.86 $5.61 Million - $7.35 Million
-620,139 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$9.05 - $12.2 $5.61 Million - $7.57 Million
620,139 New
620,139 $7.06 Million
Q1 2020

May 15, 2020

SELL
$8.58 - $14.01 $685,653 - $1.12 Million
-79,913 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$8.22 - $14.0 $656,884 - $1.12 Million
79,913 New
79,913 $1.06 Million
Q4 2018

Feb 14, 2019

SELL
$7.8 - $16.13 $297,960 - $616,166
-38,200 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$14.31 - $17.65 $15 Million - $18.5 Million
-1,046,906 Reduced 96.48%
38,200 $705,000
Q2 2018

Aug 14, 2018

BUY
$11.83 - $16.2 $12.1 Million - $16.5 Million
1,020,106 Added 1569.39%
1,085,106 $20.7 Million
Q1 2018

May 15, 2018

BUY
$11.13 - $13.63 $723,450 - $885,950
65,000 New
65,000 $1 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $663M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.